CICON24 will focus on Translating Science into Survival and feature plenaries by the leaders in the field and proffered talks selected from the submitted abstracts.
SUNDAY, SEPTEMBER 8, 2024
Keynote Lecture
Cathy Wu, Dana Farber Cancer Institute
Session 1: Neoadjuvant and Platform Trials
Tina Cascone, The University of Texas MD Anderson Cancer Center
Luis Diaz, Memorial Sloan Kettering Cancer Center
Chuck Drake, Janssen
Elizabeth Jaffee, Johns Hopkins Medicine
Mark Yarchoan, Johns Hopkins Medicine
Session 2: Multiomic Data Analysis: Searching for Mechanistic Insights (Beyond just atlas-ing)
Elana Fertig, Johns Hopkins Medicine
Ben Greenbaum, Memorial Sloan Kettering Cancer Center
Benjamin Izar, Columbia University
Session 3: Tertiary Lymphoid Aggregates as Regulators of Anti-Cancer Immunity
Tullia Bruno, University of Pittsburgh
Anna Dimberg, Uppsala University
Wolf Hervé Fridman, Cordeliers Research Center, Paris
Nir Hacohen, Massachusetts General Hospital
MONDAY, SEPTEMBER 9, 2024
Session 4: Immune Health and Inflammation as Precursors to Cancer (Cancer Interception)
Allie Greenplate, University of Pennsylvania
Max Krummel, University of California, San Francisco
Amanda Lund, New York University
Dana Pe’er, Memorial Sloan Kettering Cancer Center
Session 5: The Role of Myeloid Cells in the Anti-tumor Response
Greg Beatty, University of Pennsylvania
Jennifer Guerriero, Brigham and Women’s Hospital / Harvard Medical School
Ming Li, Memorial Sloan Kettering Cancer Center
Evanthia Roussos-Torres, University of Southern California
Session 6: Panel Discussion
What’s on the Horizon: New Tools, Technologies, and Approaches in Cancer Immunotherapy.
Moderated by: Dana Pe’er
John Marioni, Genentech
TUESDAY, SEPTEMBER 10, 2024
Session 7: Metabolism: Metabolomic Pathways in the Clinic
Marina Baretti, Johns Hopkins Medicine
Hongbo Chi, St. Jude Children’s Research Hospital
Ping-Chih Ho, University of Lausanne
Susan Kaech, Salk Institute for Biological Studies
Session 8: Microbiome --> Diet and Microbiome
Tal Danino, Columbia University
Andrew Y. Koh, University of Texas Southwestern
Saman Maleki, Western University
Maria Rescigno, Humanitas University, Milano
Jennifer Wargo, The University of Texas MD Anderson Cancer Center
WEDNESDAY, SEPTEMBER 11, 2024
Session 9: Moving toward personalized therapies: Cellular & Vaccines
Vinod Balachandran, Memorial Sloan Kettering Cancer Center
Gianpietro Dotti, UNC Lineberger Comprehensive Cancer Center
Magnus Essand, Uppsala University
Maria Themeli, University of Amsterdam
Neeha Zaidi, Johns Hopkins Medicine
Program still in formation.
Conference Co-Chairpersons
Elizabeth M. Jaffee, Johns Hopkins, Baltimore, MD
Guido Kroemer, Gustave Roussy Cancer Center, Villejuif, France
Dana Pe’er, Memorial Sloan Kettering Cancer Center, New York, NY
Özlem Türeci, BioNTech, Mainz, Germany
Committee Members
James P. Allison, University of Texas M.D. Anderson Cancer Center, Houston, TX
Tullia Bruno, University of Pittsburgh, Pittsburgh, PA
Giulia Casorati, IRCCS Ospedale San Raffaele, Milan, Italy
Yvonne Chen, UCLA, Los Angeles, CA
Lisa Derosa, Gustave Roussy Cancer Center, Villejuif, France
Mustafa Diken, TRON-Translational Oncology, Mainz, Germany
Wolf Hervé Fridman, Cordeliers Research Center, Paris, France
Ming Li, Memorial Sloan Kettering Cancer, New York, NY
Johanna Olweus, Oslo University Hospital, Oslo, Norway
Ellen Puré, University of Pennsylvania, Philadelphia, PA
Antonio Sica, IRCCS Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
Gregory Sonnenberg, Weill Cornell Cancer Center, New York, NY